| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chairman &CEO
1 company
O'Day Daniel Patrick is a Chairman &CEO at GILD. Recent filings cover 0 purchases and 37 sales. Those positions are worth an estimated $84.2M at current prices.
Our model assigns O'Day Daniel Patrick a below-average insider score of 40/100, based on 10 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -18.8%.
O'Day Daniel Patrick's largest disclosed position is in GILD as Chairman &CEO, worth about $84.2M. The recent filings there lean toward selling, a net 426,280 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | GILD Gilead Sciences, Inc. | Chairman &CEO | Sell | 15,000 | $147.90 | $2,218,507.50 | -2.6% | - | - | |
| Sep 1, 2026 | GILD Gilead Sciences, Inc. | Chairman &CEO | Sell | 15,000 | $148.64 | $2,229,592.04 | -2.5% | - | - | |
| Aug 3, 2026 | GILD Gilead Sciences, Inc. | Chairman &CEO | Sell | 15,000 | $130.31 | $1,954,693.53 | -2.5% | - | - | |
| Jul 1, 2026 | GILD Gilead Sciences, Inc. | Chairman &CEO | Sell | 15,000 | $126.29 | $1,894,399.93 | -2.4% | +20.1% | - | |
| Jun 1, 2026 | GILD Gilead Sciences, Inc. | Chairman &CEO | Sell | 15,000 | $131.46 | $1,971,846.67 | -2.4% | +11.6% | - | |
| Apr 28, 2026 | GILD Gilead Sciences, Inc. | Chairman &CEO | Sell | 10,000 | $129.16 | $1,291,608.37 | -1.6% | +1.0% | - | |
| Mar 27, 2026 | GILD Gilead Sciences, Inc. | Chairman &CEO | Sell | 10,000 | $136.82 | $1,368,162.00 | -1.5% | -7.8% | - | |
| Feb 27, 2026 | GILD Gilead Sciences, Inc. | Chairman &CEO | Sell | 10,000 | $144.79 | $1,447,858.62 | -1.5% | -8.5% | - | |
| Feb 5, 2026 | GILD Gilead Sciences, Inc. | Chairman &CEO | Sale+OE | 115,640 | $150.00 | $17,346,000.00 | -15.9% | -8.8% | - | |
| Jan 28, 2026 | GILD Gilead Sciences, Inc. | Chairman &CEO | Sell | 10,000 | $139.89 | $1,398,911.15 | -1.8% | -7.5% | - |